Merck to Pay $688 Million Settlement

Merck agreed to pay $688 million to settle lawsuits claiming that shareholders lost money when the company reported negative results of a clinical trial of cholesterol-lowering drug Vytorin in 2008.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news